HAEM5:Volunteer Assignments and Opportunities: Difference between revisions

[unchecked revision][unchecked revision]
No edit summary
No edit summary
Line 1,550: Line 1,550:
|[[HAEM5:In situ follicular B-cell neoplasm|In situ follicular B-cell neoplasm]]
|[[HAEM5:In situ follicular B-cell neoplasm|In situ follicular B-cell neoplasm]]
|Disease
|Disease
|Rachel D. Burnside, PhD, MBA, FACMGG
|7/28/2023
|
|
|
|Pending
|
|
|
|
|SG
|SG
|
|
|
|
|In situ follicular B-cell neoplasm
|In Situ Follicular Neoplasia
|Rachel D. Burnside, PhD, MBA, FACMGG
|Rachel D. Burnside, PhD, MBA, FACMGG
|Pending
|Pending
|
|
|Author assigned on 7/28/2023
|
|-
|-
|[[HAEM5:Follicular lymphoma|Follicular lymphoma]]
|[[HAEM5:Follicular lymphoma|Follicular lymphoma]]
|Disease
|Disease
|Rachel D. Burnside, PhD, MBA, FACMGG
|7/28/2023
|
|
|
|Pending
|
|
|
|
|SG
|SG
|
|
|
|Author also needs to correlate with 4th edition disease "Testicular Follicular Lymphoma", which is no longer a separate entity
|
|Follicular Lymphoma + Testicular Follicular Lymphoma
|Ruthann Pfau, PhD, FACMG, Nationwide Children's Hospital  Rachel D. Burnside, PhD, MBA, FACMG, University of Florida
|Ruthann Pfau, PhD, FACMG, Nationwide Children's Hospital  Rachel D. Burnside, PhD, MBA, FACMG, University of Florida
|
|Pending
|
|
|
|